Aureus Asset Management, LLC / TMO
Aureus Asset Management, LLC’s Thermo Fisher Scientific Inc Position
Does Aureus Asset Management, LLC own Thermo Fisher Scientific Inc (TMO)? Yes — 76.1K shares worth $37M (+2.49% of its 13F portfolio) as of Q1 2026, down from 76.8K shares the prior filed quarter.
Position Value
$37M
Q1 2026
Shares
76.1K
% of Portfolio
+2.49%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 76.1K | $37M | +2.49% |
| Q4 2025 | 76.8K | $45M | +2.84% |
| Q3 2025 | 77.1K | $37M | +2.43% |
| Q2 2025 | 78.3K | $32M | +2.03% |
| Q1 2025 | 56.5K | $28M | +1.97% |
| Q4 2024 | 57.0K | $30M | +1.92% |
| Q3 2024 | 57.9K | $36M | +2.34% |
| Q2 2024 | 58.4K | $32M | +2.26% |
| Q1 2024 | 59.3K | $34M | +2.35% |
| Q4 2023 | 59.3K | $31M | +2.30% |
| Q3 2023 | 60.1K | $30M | +2.44% |
| Q2 2023 | 62.2K | $32M | +2.43% |
| Q1 2023 | 51.0K | $29M | +2.32% |
| Q4 2022 | 50.9K | $28M | +2.42% |
| Q3 2022 | 50.7K | $26M | +2.24% |
| Q2 2022 | 51.6K | $28M | +2.26% |
| Q1 2022 | 51.5K | $30M | +2.02% |
| Q4 2021 | 70.0K | $47M | +2.88% |
| Q3 2021 | 70.8K | $40M | +2.66% |
| Q2 2021 | 69.3K | $35M | +2.25% |
| Q1 2021 | 67.0K | $31M | +2.37% |
| Q4 2020 | 64.2K | $30M | +2.52% |
| Q3 2020 | 63.6K | $28M | +2.66% |
| Q2 2020 | 61.3K | $22M | +2.42% |
| Q1 2020 | 60.3K | $17M | +2.37% |
| Q4 2019 | 60.0K | $20M | +2.18% |
| Q3 2019 | 59.5K | $17M | +2.16% |
| Q2 2019 | 60.0K | $18M | +2.17% |
| Q1 2019 | 58.4K | $16M | +2.12% |
| Q4 2018 | 55.5K | $12M | +1.95% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aureus Asset Management, LLC’s full portfolio or all institutional holders of TMO.